Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals
- 1 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (12) , 1700-1701
- https://doi.org/10.1097/00002030-200208160-00024
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Longitudinal predictors of depressive symptoms among low income injection drug usersAIDS Care, 2001
- Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirinAIDS, 2001
- Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?New England Journal of Medicine, 2001
- Syringe prescription to prevent HIV infection in Rhode Island: a case studyAmerican Journal of Public Health, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Aggressive Daily Interferon Therapy in HIV-HCV Coinfected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Hepatitis C, interferon alfa, and depressionHepatology, 2000
- Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2000
- Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfectionThe American Journal of Medicine, 1999
- Hepatitis C and depressionDepression and Anxiety, 1998